99mTc-MAA-SPECT/CT联合锥形束CT优化放射性栓塞规划
该研究纳入24例接受放射性栓塞治疗的患者,比较增强CT、99mTc-MAA-SPECT/CT与锥形束CT预测最终靶体积的准确性及对剂量计算的影响。结果显示99mTc-MAA-SPECT/CT对90Y PET/CT靶体积的预测优于锥形束CT和增强CT,剂量学值也更接近;锥形束CT则提供确保肿瘤全覆盖及多供血动脉时按灌注体积分配活度的关键信息。联合使用两者可优化放射性栓塞的剂量学规划。
要点
- 99mTc-MAA-SPECT/CT预测90Y PET/CT靶体积优于锥形束CT和增强CT。
- 99mTc-MAA-SPECT/CT的剂量学值更接近90Y PET/CT所得值。
- 锥形束CT确保肿瘤全覆盖并支持多供血动脉时按灌注体积分配活度。
核心结论
- 联合使用99mTc-MAA-SPECT/CT与锥形束CT可优化放射性栓塞的剂量学规划,实现更精准的个体化治疗。
研究设计与样本
- 连续纳入24例接受放射性栓塞治疗的患者,分别获取99mTc-MAA-SPECT/CT、增强CT和锥形束CT的靶体积,并与90Y PET/CT靶体积比较。
- 使用各影像模态估计的靶体积和虚构活度1 GBq,计算每例患者肿瘤及非肿瘤实质的吸收剂量,并与基于90Y PET/CT靶体积所得剂量比较。
主要发现
- 99mTc-MAA-SPECT/CT对90Y PET/CT靶体积的预测优于锥形束CT或增强CT,即使在选择性或超选择性给药时亦然。
- 99mTc-MAA-SPECT/CT显示的剂量学值与90Y PET/CT所得值更相似。
- 锥形束CT为放射性栓塞规划提供关键信息,如确保肿瘤完全覆盖,以及在存在多条供血动脉时按各动脉灌注的肿瘤体积分配活度。
临床怎么用
- 放射性栓塞术前规划可联合使用99mTc-MAA-SPECT/CT与锥形束CT,以更准确预测靶体积和剂量学。
- 利用锥形束CT确认肿瘤全覆盖,并在多供血动脉时依据各动脉灌注肿瘤体积分配活度。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To determine which imaging method used during radioembolization (RE) work-up: contrast-enhanced computed tomography (CECT), 99mTc-MAA-SPECT/CT or cone beam-CT (CBCT), more accurately predicts the final target volume (TgV) as well as the influence that each modality has in the dosimetric calculation. METHODS: TgVs from 99mTc-MAA-SPECT/CT, CECT and CBCT were consecutively obtained in 24 patients treated with RE and compared with 90Y PET/CT TgV. Using the TgVs estimated by each imaging modality and a fictitious activity of 1 GBq, the corresponding absorbed doses by tumor and non-tumoral parenchyma were calculated for each patient. The absorbed doses for each modality were compared with the ones obtained using 90Y PET/CT TgV. RESULTS: 99mTc-MAA-SPECT/CT predicted 90Y PET/CT TgV better than CBCT or CECT, even for selective or superselective administrations. Likewise, 99mTc-MAA-SPECT/CT showed dosimetric values more similar to those obtained with 90Y PET/CT. Nevertheless, CBCT provided essential information for RE planning, such as ensuring the total coverage of the tumor and, in cases with more than one feeding artery, splitting the activity according to the volume of tumor perfused by each artery. CONCLUSION: The joint use of 99mTc-MAA-SPECT/CT and CBCT optimizes dosimetric planning for RE procedures, enabling a more accurate personalized approach.
引用
- Rodríguez-Fraile M, Ezponda A, Grisanti F, et al. The joint use of 99mTc-MAA-SPECT/CT and cone-beam CT optimizes radioembolization planning. EJNMMI Res. 2021. PMID: 33661428. doi:10.1186/s13550-021-00764-z
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。